Swiss Lonza completes $300m acquisition of US' InterHealth

摘要

SINGAPORE (ICIS)--Lonza has completed the acquisition of US firm InterHealth Nutraceuticals, Inc from investment firm Kainos Capital, the Swiss producer said on Tuesday. The acquisition, worth up to $300m, is expected to be immediately earnings accretive, the company said in a statement.